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Abstract
Background: Gene expression profiling of uterus tissue has been performed in various contexts, but a significant amount of
the data remains underutilized as it is not covered by the existing general resources.
Methodology/Principal Findings: We curated 2254 datasets from 325 uterus related mass scale gene expression studies on
human, mouse, rat, cow and pig species. We then computationally derived a ‘reliability score’ for each gene’s expression
status (transcribed/dormant), for each possible combination of conditions and locations, based on the extent of agreement
or disagreement across datasets. The data and derived information has been compiled into the Mammalian Gene Expression
Uterus database (MGEx-Udb, http://resource.ibab.ac.in/MGEx-Udb/). The database can be queried with gene names/IDs,
sub-tissue locations, as well as various conditions such as the cervical cancer, endometrial cycles and disorders, and
experimental treatments. Accordingly, the output would be a) transcribed and dormant genes listed for the queried
condition/location, or b) expression profile of the gene of interest in various uterine conditions. The results also include the
reliability score for the expression status of each gene. MGEx-Udb also provides information related to Gene Ontology
annotations, protein-protein interactions, transcripts, promoters, and expression status by other sequencing techniques,
and facilitates various other types of analysis of the individual genes or co-expressed gene clusters.
Conclusions/Significance: In brief, MGEx-Udb enables easy cataloguing of co-expressed genes and also facilitates bio-
marker discovery for various uterine conditions.
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Introduction
Uterus is an important mammalian organ that must be well
studied for its role in normal functions such as sperm migration,
embryo implantation and fetal nourishment, as well as multiple
disorders [1,2]. Cervical cancer is one of the leading causes of
cancer deaths in women worldwide [3]. Similarly, endometrial
cancer, endometriosis and infertility due to defective uterine
functions have also been major human health concerns. Much
remains unknown about the normal physiology and pathological
details of the uterus tissue.
Understanding the pattern and mechanisms of regulation of
gene expression is central to most aspects of biology, including the
normal and abnormal states of the mammalian uterus. Large-scale
detection of gene expression patterns is easier at the transcript level
when compared to the protein level. Microarrays enabled genome
wide transcript profiling and they have been used extensively to
explore various biological phenomena.
Variations in the expression level and status of genes, across the
results of microarray experiments [4], have caused limitations in
the utilities of such gene expression data. Recommended standards
for microarray experiments and reporting [5–7], and improved
meta-analysis methods [8–11] might facilitate a better use of the
reported data. While scientists today seem to prefer sequencing
based methods for transcript profiling [12,13], the value of the
already existing microarray data cannot be underestimated.
Microarray and other high-throughput gene expression data have
been compiled into multiple useful databases/repositories (for a list,
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efficiencies in search options specific to physiological and
experimental conditions also limit the exploitation of the available
databases. It has also been observed that a significant amount of
the data is missing in such databases [14,15]. Compiling most of
the expression data in one place would be a huge challenge due to
two main reasons: a) gathering the data scattered in literature is
a laborious task, but there seems to be no alternative; b) there has
not been a convenient means to derive usable information across
different platforms, studies and data types (raw/processed data or
the final calls only). Our team earlier spent around 3 years to
painstakingly compile gene expression data for the mammalian
testis, and then applied the novel consensus based reliability
assessment method to derive a binary expression status for each
gene [15].
A similar effort is required for the uterus tissue. Significant
amount of microarray data is indeed available for the mammalian
uterus tissue [16]. There have been a few databases specific to
a component of uterus such as endometrial tissue, (Endometrial
Data Base: http://www.endometrialdatabase.com and SCCPIR
Endometrium Database Resource: http://endometrium.bcm.tmc.
edu/edr) or to a condition, CCDB, Cervical Cancer gene
DataBase [17]. But, there has not been a uterus specific database.
With an intention to compile maximum existing uterine gene
expression data and aid research on various aspects of mammalian
uterus, we have created the Mammalian Gene Expression Uterus
database (MGEx-Udb), and are reporting the same.
Results
Database content
(A) Data considered for scoring: Currently, the database covers
325 studies with 2254 datasets corresponding to 1092 ‘Expression
Status under specific Locations and Conditions’ (ESLCs) for
human, mouse, rat, cow and pig. About 83% of the data in
MGEx-Udb is from studies on human species (Figure 1). The
database provides 970 different ESLCs for human (23,735 genes),
91 for mouse (24,428 genes), 15 for rat (14,497 genes), 8 for cow
(10,875 genes), and 8 for pig (1,720 genes). The database has
maximum number of studies for cervical cancer (38% of all
studies). The next most abundant studies correspond to endome-
trial cancer and endometriosis (approximately 13% studies for
each). Other contributing conditions include the normal, leio-
myoma, leiomyosarcoma, cervical intraepithelial neoplasia (CIN),
endometrial hyperplasia, endometrial cycles, gestation, treatment
with chemicals/hormones and knockout and transfection studies
associated with specific genes (Figure 2). Most disease related
reports are from human tissues and/or cell lines. While studies
related to hormone treatment, embryo implantation and normal
tissue are common in mouse, studies on chemical/hormone
treatment and endometriosis are common in rat. In case of cow
and pig, pregnancy related studies are common.
Of the 325 studies identified for data collection, 295 published
research articles were curated to collect the information associated
with each gene list. In remaining cases, the required information
was curated directly from repositories; there was no corresponding
publication for these experiments. Of all the studies, around 55%
were exclusively obtained from literature. The remaining data
came from Gene Expression Omnibus (GEO) [18], ArrayExpress
[19] and other repositories alone, or in combination with literature
(Figure 1). In the database, 90% of studies correspond to mRNA
level expression and 10% studies correspond to expression at
proteomic level. Most (91%) of the mRNA level reports came from
microarray technology, which also contributes to 72% of the total
datasets. Affymetrix (66%) is the leading contributor among the
microarray platforms, followed by cDNA custom arrays (21%)
(Figure 3). Small-scale studies based on reverse transcription
Polymerase Chain Reaction (PCR), quantitative real time PCR,
blotting techniques, etc., also contributed datasets. Among the
total datasets, 52% have .500 genes in each, 8% of them have
50–500 and the remaining 40% contain ,50 genes (Figure 4). In
most cases, datasets corresponding to small-scale studies were from
the validation experiments of a mass scale gene expression study.
B) Data not considered for scoring: MGEx-Udb also has
sequencing data. Such data could not be employed in scoring the
consensus due to the incompatibility of these data types with the
current computational scoring system. Next Generation Sequenc-
ing (NGS) data was included for HeLa cells with differential
expression calls for 2 treatment conditions, from 3 studies. Links
are provided for other relevant NGS (raw) datasets. Bulk of the
sequencing data, however, corresponds to Expressed Sequence
Tags (ESTs).
Web interface
Query features. MGEx-Udb provides multiple query op-
tions. To query by a gene, user can enter identifiers of one of the
following types: names, symbols, synonyms, Entrez gene IDs, and
gene keywords/descriptions. Condition-based search can be done
by selecting the condition of interest from the drop-down options
of physiological or experimental conditions at different levels of
hierarchies for a chosen species. For example, genes transcribed or
dormant can be obtained for human cervical cancer as well as,
squamous cell carcinoma condition. Similarly, queries can be
restricted to a specific region of the tissue (sub-tissue), and cell-
type. There is also an option to choose a specific population type
such as Caucasian, in case of humans, and strain types such as
C57BL6 or Sprague-Dawley in case of mouse and rat, re-
spectively.
Output. For gene-based search, the database provides a list of
identical as well as partially matching genes in different species.
Each gene in this page can be clicked for basic information on the
gene, their promoters, expression status, products (transcripts and
proteins), Gene Ontology (GO) annotations, protein-protein
interactions, cross-reference to other major bioinformatics re-
sources, and relevant PubMed citations. Basic gene information
consists of sequence, loci and gene summary. Transcript in-
formation includes transcript ID, coding sequence and exon-
intron details. Promoter details cover the Transcription Start Site
(TSS), potential promoter sequence and its chromosomal position.
Protein information provides different isoforms of the protein(s),
with corresponding sequence, function, molecular weight and
amino acid length. Expression status(s) of the gene is shown, along
with a reliability score, for multiple tissue regions/sub-tissue and
cell-types under different physiological and experimental condi-
tions. The original source of the expression data is displayed in
a separate panel. In addition to this, the database shows an
indicative expression status(s) based on sequencing data (EST &
NGS), for various uterine tissues/conditions.
Query with a condition (condition-based search) provides lists of
genes transcribed and dormant in the queried condition. In each
of these two lists, the ‘reliability score’ is shown for every gene. In
fact, the genes are arranged in the descending order of their scores.
GO annotations are also displayed for the first 100 genes. The user
can export the complete list of genes along with their reliability
scores. References to the source datasets considered for scoring
can be viewed in this output page. Clicking on any gene in the
result page will be similar in effect to the gene specific query
described in the previous paragraph. The ‘analyze’ option in the
Uterine/Cervical Gene Expression Profiles
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36776Figure 1. Source of data across various mammalian species in MGEx-Udb. Other species include cow and pig. Among the data collected
from GEO or ‘‘PubMed & GEO’’, 85% of the studies were also present in ArrayExpress, even though this is not indicated in the figure.
doi:10.1371/journal.pone.0036776.g001
Figure 2. Number of datasets (and studies) in MGEx-Udb corresponding to various physiological and pathological uterine
conditions. ‘Others’ represent post-parturition, genetic-ablation, artificial insemination and embryo implantation. Studies considering tissues that
are used as controls but may not be absolutely ‘normal’ have been grouped in ‘may be normal’ category (examples: ‘‘normal tissue adjacent to tumor/
cancer tissue’’, ‘‘vehicle-treated’’).
doi:10.1371/journal.pone.0036776.g002
Uterine/Cervical Gene Expression Profiles
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functions/processes of the selected genes. The user can quickly
initiate GO analysis and multiple sequence alignment (of genes,
proteins and promoters), and easily access relevant pathways and
Single Nucleotide Polymorphism (SNP) records. The database also
permits co-expression, protein-interaction and pathway analyses,
and offers visualization of the networks among the selected cluster
of genes using GeneMANIA [20] functional analysis tool.
The database includes easy browsing of genes and conditions. In
addition, links are provided to uterus related data (NGS and copy
number variations), with an index of conditions, and other
resources.
Discussion
A significant amount of the published microarray data is not
found in any of the widely used databases or repositories [14,15].
Compilation of such data has to be manual and would be a time
taking process. We have initiated tissue wise compilation of
mammalian gene expression data with an aim to use the existing
data for cataloguing the gene expression patterns. A comparative
study [15] of the databases with condition specific queries
indicated the superiority of such tissue wise biocuration of the
gene expression data. A similar comparison of MGEx-Udb with
other repositories/databases showed that former provides easier
query system and provides higher number of relevant studies and
genes (details in statistics section of the database).
The strength of the ‘reliability score’, for the binary expression
status, is proportional to the amount of datasets and agreement
across them, for any corresponding condition. There are some
limitations [15] in such consensus based scoring of the binary
expression states. But, this binary consensus method does offer
a significant advantage over most other meta-analysis methods in
deriving a semi-quantitative consensus. It works across platforms
and technologies, irrespective of availability of raw/processed data
as long as the final call has been made.
The hierarchical display of genes transcribed/dormant in
specific conditions can be a useful representation of the
transcription profiles. The higher scores indicate consistency in
expression status of the corresponding genes across biological
samples (used in different studies) and technologies. In fact, the
consistency seems to be maintained for many genes despite the
variations in the technology such as the microarray platform, RNA
isolation methods and statistics, as well as the samples, which could
also vary in terms of populations/strains and other related aspects
such as age, social interactions and diet. The resulting lists can be
used to identify genes that have strong association with any
physiological status/condition in mammalian uterus tissue. For
Figure 3. Datasets across various microarray platforms in
MGEx-Udb. ‘Others’ include datasets contributed mainly by GE
Healthcare and Illumina platforms.
doi:10.1371/journal.pone.0036776.g003
Figure 4. Datasets (with gene count) collected from various sources. In case of ‘‘PubMed & GEO’’ and ‘‘PubMed & ArrayExpress’’, smaller gene
lists came from validation experiments and were collected from PubMed, while raw/processed data were always collected from the repositories
(GEO/ArrayExpress).
doi:10.1371/journal.pone.0036776.g004
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dormant in the disease condition of interest and compare with
those having the opposite expression status in the normal
condition. A union list of genes across the two conditions can be
derived and hierarchically arranged based on scores. Such a list
would include genes with varying degrees of association with the
disease. As an example, the genes ‘‘transcribed in cervical cancer but
dormant in normal cervix/uterus’’ with high reliability scores may be
better candidate bio-markers than the genes usually identified as
differentially expressed by a single study. CDKN2A, which is an
already well-known marker for cervical cancer [21,22], is one such
gene that has a score of 318 for ‘transcribed status in cervical cancer’
from 79 studies from PubMed, 6 from GEO, 1 from ArrayExpress
and 2 from caArray, and 88 for ‘dormant status in normal uterus’, from
32 studies from PubMed and 1 from GEO. On the contrary, some
of the top genes from the dormant list for cervical cancer were also
dormant in normal uterus, and hence they are less likely to have
a strong association with the disease. Thus, the output obtained
across conditions can be used to differentiate genes that have
strong association with a uterine condition from those with weak
or no association. This approach could pave a new way of listing
potential diagnostic, prognostic and therapeutic targets for the
uterus related disorders. This process can be used to obtain refined
clusters of co-expressed genes.
The gene clusters obtained by MGEx-Udb can be useful not
only to understand the molecular mechanisms and pathways
associated, but also to elucidate the mechanisms of transcriptional
regulation, disease-stage identification, gene prioritization and
gene function predictions. We have initiated some studies in the
promoter analysis of some of the important clusters of co-
expressed genes. The compiled (after a huge screening effort) list of
references of the gene lists corresponding to each condition and
location of interest can be particularly useful for users interested in
applying other meta-analysis methods to the gene expression data.
Since MGEx-Udb provides most or all of the genes associated
with a specific condition, it may serve as a good starting point for
any kind of functional analysis for various uterine conditions.
MGEx-Udb also provides an opportunity to compare gene
expression patterns across subtle variations in conditions and
treatments. For example, one can compare expression status from
untreated normal tissue reports with those from sham/vehicle-
treated samples (may be normal); tumor-adjacent tissues (may be
normal) with tumor-lacking tissues (normal); uterine layers/cycles;
stages of cancer etc - across studies.
The already existing resources that correspond to specific
uterine sub-tissues/conditions are advantageous in some ways
compared to MGEx-Udb. Hence, we have included links to such
resources in our database. CCDB [17], a database specific to
cervical cancer, not only provides up/down regulated, methylated,
mutated and amplified genes, but also gives information on
miRNAs related to cervical cancer. Endometrial Data Base
(http://www.endometrialdatabase.com) and the SCCPIR Endo-
metrium Database Resource (http://endometrium.bcm.tmc.edu/
edr) compile several reports of differential gene expressions in
endometrial conditions. But, apart from being limited to specific
conditions, their gene coverage does seem to be less than MGEx-
Udb. They are also not designed to provide a consensus expression
status through meta-analysis, or facilitate such process. On the
other hand, tissue specific databases such as TiGER [23] and
TiSGeD [24] provide uterus specific genes, but do not allow
specific queries for diseases and/or experimental conditions.
Future developments
The current work has taken us 3 years, mainly due to the
manual curation tasks involved. Data corresponding to some
conditions and species is yet to be included and the scoring for
binary status has its limitations. We intend to update the database
with data for more mammalian species and uterine conditions by:
a) inviting fellow scientists to upload the data, and b) our own
efforts following additional funding. We are also planning to
improve the scoring system in many ways: a) different weight
assignment based on the number of samples, hybridizations and
validation experiments; b) incorporate consensus on the differen-
tial expression status along with transcribed/dormant status; c)
perhaps in collaboration with other organizations, establish
methods to incorporate data from other high-throughput gene
expression data, such as NGS and EST, while deriving the
consensus.
Summary
The newly developed MGEx-Udb is intended to boost multiple
types of efforts by biologists working on the uterus tissue. The
important applications/features of this database are the following.
A) It includes a large amount of manually compiled gene
expression data corresponding to uterus from various reports
and databases. B) It provides a catalogue of co-expressed genes in
various normal and abnormal uterine conditions. C) It provides
a ‘‘reliability score’’ to indicate the extent of agreement or
contradictions of the expression status across microarray and
Figure 5. Example hierarchy of the conditions and sub-conditions. An example (‘‘stage IIA non-keratinizing squamous cell cervical carcinoma’’)
hierarchy of the conditions and sub-conditions, for which data have been collected, and drop-down options provided in the query and upload pages
of MGEx-Udb. Currently the database allows up to four levels of the hierarchy to query.
doi:10.1371/journal.pone.0036776.g005
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each gene. D) It also uses sequencing data in various uterine
tissues/conditions to indicate expression status of each gene. E)I t
can be queried with normal or any of the pathological conditions
in uterus, as well as the genes, of mouse, rat and human species. F)
In addition to the expression status along with reliability scores for
multiple uterine conditions, the database provides easy access to
other important basic details such as the sequences of the genes,
proteins and transcripts, GO annotations, protein-protein inter-
actions and the relevant citations. G) It allows performing
sequence and functional analyses of the derived co-expressed sets
of clusters. H) Every gene is also cross-referenced to other useful
bioinformatics resources. I) It provides an easy access to the
compiled list of references of gene lists corresponding to various
uterine conditions, useful for various meta-analysis approaches. All
these features are likely to catalyze the process of transcript
cataloguing, and various other uterus related research efforts.
Materials and Methods
Data collection
A search strategy was carefully designed to collect relevant
articles reported in the literature, (detailed procedure can be found
at http://dx.doi.org/10.1038/npre.2011.2101.3). Briefly, this in-
volved identifying combinations of query terms/phrases for each
search tool, obtaining the citations using multiple tools and then
compiling the hits into a non-redundant union list using the
Citation-Compiler tool (http://www.shodhaka.com/compiler).
An example of the complete search strategy and query sets can
be found in the FAQs section of the database. The aim was to
collect citations related to mass scale gene expression in uterus
tissue. An initial screening of the articles was performed to verify
Figure 6. Schematic representation of MGEx-Udb. The figure represents the data collection (top portion), architecture (central portion) and
operation (bottom portion) of the database.
doi:10.1371/journal.pone.0036776.g006
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relevant were then searched for the list of genes reported to be
expressed, up-regulated, down-regulated, etc by a thorough full
text reading. Gene lists from these relevant articles were collected
from manuscript, supplementary notes or the authors’ website.
Major repositories such as the GEO [18] and ArrayExpress [19],
and other repositories such as Oncomine [25], Stanford Micro-
array Database (SMD) [26], Center for Information Biology gene
EXpression database (CIBEX) [27], caArray (https://array.nci.
nih.gov/caarray), GEMMA (http://www.chibi.ubc.ca/Gemma/)
and Public Expression Profiling Resource (PEPR) [28] were also
searched for the large scale gene expression data pertaining to
mammalian uterus tissue. Processed data was collected wherever
available, as the scoring method only requires the final call about
the present/absent status of the genes. If there was no processed
data, raw data was downloaded and processed using suitable
standard methods as recommended in the Bioconductor packages
(http://www.bioconductor.org).
Along with the gene list, associated information such as the
expression status, species, tissue and sub-tissue or cell line, cell-
type, and the corresponding physiological or experimental
conditions were collected from the publications or repositories.
This set of basic parameters is henceforth referred to as
‘Expression Status under specific Location and Condition’ (ESLC).
The ‘conditions’ include normal physiological state, diseases,
endometrial cycles, gestation, treatment with hormones and/or
other chemicals, etc. A controlled vocabulary was set for each
condition, to maintain the uniformity and to derive the consensus
across similar studies. Figure 5 illustrates the hierarchy of
a condition and multi-level sub-conditions. Other information
collected about the gene lists included the number of samples, age
of individuals, number of RNA isolations and hybridizations, and
the details of main as well as validation experiments (example:
platform, probes and statistical methods). These gene lists along
with the annotated information (henceforth referred to as datasets)
were uploaded to the database. The minimum number of genes
per dataset was 3, the maximum was 21609, and the average was
8554. Every entry was cross-checked by at least one other
researcher and, on an average 0.7% errors (e.g., gene chip name,
population type, time course of treatment) were detected and
rectified.
A ‘reliability score’ was derived for every ESLC of each gene,
using procedures described earlier [15], to indicate the extent of
agreement or disagreement across datasets, which correspond to
same or similar conditions and locations for each species. Higher
scores indicate that the corresponding genes are consistently
reported to be transcribed or dormant. Genes with lower scores for
the same/similar conditions would indicate either lesser number of
corresponding studies or presence of contradicting reports for the
specific expression status under consideration.
Sequencing data related to uterine tissues/conditions was also
compiled. While reports on RNA sequencing were collected from
literature, EST data was directly taken from UniGene [29].
Database creation
Perl based CGI script was used to create an interface for entry
of gene lists and associated information. An in-house database was
used to convert the gene identifiers from the datasets into Entrez
gene identifiers. These Entrez gene identifiers were queued-up for
downloading other gene related information. LWP module
(http://search.cpan.org/ ˜gaas/libwww-perl-5.836/lib/LWP.pm)
was used to connect to NCBI and the required information was
downloaded with the aid of NCBI E-utilities (http://eutils.ncbi.
nlm.nih.gov/entrez/query/static/eutils_help.html). Downloaded
information includes official gene symbol, aliases, gene sequence,
gene summary, chromosomal location, potential promoter se-
quence [21000 to +200 bp] and all transcript sequences (along
with exon-intron details) corresponding to each gene. Protein
related information was downloaded from UniProt (http://www.
uniprot.org; [30]). Similarly, transcription start sites were down-
loaded from dbTSS (ftp://ftp.hgc.jp/pub/hgc/db/dbtss/; [31]),
version 7.0. When the information was not available in dbTSS for
a gene, the 59 end of corresponding NCBI gene sequence was used
to represent the TSS position. Gene Ontology information was
downloaded from the ftp site of the database (ftp://ftp.
geneontology.org/pub/go/; [32]) and protein-protein interaction
information was downloaded from BioGRID (http://thebiogrid.
org/download.php; [33]), version 3.1. EST data was downloaded
from UniGene (ftp://ftp.ncbi.nih.gov/repository/UniGene; [29]).
Perl codes were written to ensure automatic incorporation of the
downloaded data into the database. ClustalW was downloaded
from http://www.clustal.org/clustal2/ and integrated into data-
base, to provide facility to perform multiple sequence analysis.
MySQL Relational Database Management System (RDBMS) is
used for storing data. A table is dedicated to store the basic gene
related information including the gene name, locus and transcript
details. Another table is used to store gene identifiers such as the
gene name, gene description, official gene symbol and the NCBI
gene identifier, microarray platform probe identifiers, etc.
Separate tables are maintained to store information related to
species, cell-type, tissue, cell line and conditions which make up
ESLC. Each entry in these non-redundant tables is tagged with
unique identifier. The results obtained from scoring system are
maintained as flat file database. Each file corresponds to unique
ESLC, which is named using identifiers from ESLC tables. The
complete database architecture and function is represented in
a schematic in Figure 6.
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